The BHRF1 protein of Epstein-Barr virus (EBV) is a structural and func
tional homolog of the Bcl-2 protein, Both BHRF1 and Bcl-2 proteins pro
mote the survival of cells exposed to various apoptotic stimuli. This
promotion of cell survival is associated with a block in proliferation
, It is believed that the Bcl-2 family of anti-apoptosis proteins cont
ribute to oncogenesis merely by promoting cell survival. We have disco
vered that mutations within a regulatory domain of the BHRF1 protein n
ot only suppress apoptosis induced by the tumor suppressor protein p53
, but also permit efficient proliferation of cells that would otherwis
e undergo total apoptosis, These gain-of-function mutants of BHRF1 coo
perate more efficiently with the E1a oncogene in transformation of pri
mary rat kidney cells where E1A expression results in apoptosis. Our r
esults suggest that such mutational inactivation of a proliferation-re
straining activity in the BHRF1 gene may play a direct role in oncogen
esis.